[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 7, 1968

Management of Clinical Tetanus

Author Affiliations

San Francisco

JAMA. 1968;206(2):375. doi:10.1001/jama.1968.03150020091025

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  The article "Tetanus" (204:614, 1968) contains statements and recommendations which should be challenged.First, the author has confused aluminum phosphate adsorbed toxoid with alum toxoid. These materials have similar uses but are not identical.Second, a recommendation that oxytetracycline be administered to patients as prophylaxis against possible tetanus in the place of antitoxin of animal origin (if human hyperimmune globulin is not available) is not justifiable. Tetracycline-resistant clostridia have been reported, and certainly tetracycline could not be relied upon to penetrate into poorly vascularized areas likely to harbor the development of Clostridium tetani. Penicillin, which might penetrate because of the higher levels which can be safely attained is the antibiotic of choice for the eradication of clostridia, but if the patient needs antitoxin, antibiotics are no suitable substitute.Third, the daily administration of equine or bovine antitoxin may perhaps increase the incidence or severity of serum sickness